Up-regulated mRNA and protein expressions of LPL, PPAR-α, CYP7A1 and CPT1, down-regulated PPAR-γ and C/EBP-α in liver of NAFLD mice. This evidence concerns the gene LPL and metabolic dysfunction-associated steatotic liver disease.